61
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, May 10, 2016: US09333359 (1 worldwide citation)

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 100 KHz may be applied to the patient's spinal cord region ...


62
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, March 24, 2015: US08989865 (1 worldwide citation)

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 100 KHz may be applied to the patient's spinal cord region ...


63
Yougandh Chitre, Cheuk Tang: Self-sealing insulation employed on a catheter or lead. Pacesetter, April 1, 2008: US07353066 (1 worldwide citation)

An implantable electrical medical lead for a pulse generator includes a distal electrode, a connector for electrical connection with the pulse generator, an electrical conductor within the lead extending between the connector and the distal electrode, and an insulating sheath of flexible resilient m ...


64
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro, Perkins Coie, February 5, 2019: US10195433

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, a programmer has instructions that, in response to an input, select between at least first and second sets of therapy signal para ...


65
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, May 3, 2016: US09327126

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region t ...


66
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, May 10, 2016: US09333357

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region t ...


67
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, May 3, 2016: US09327125

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region t ...


68
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, May 10, 2016: US09333360

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 100 KHz may be applied to the patient's spinal cord region ...


69
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, November 1, 2016: US09480842

A spinal cord modulation system is disclosed. While in one embodiment the system is used for the treatment of pain, other embodiments are also provided. In particular embodiments, the spinal cord modulation system generates and delivers an electrical therapy signal at a frequency of 10 kHz to addres ...


70
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, May 10, 2016: US09333358

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 100 KHz may be applied to the patient's spinal cord region ...